Clinical Trials Directory

Trials / Completed

CompletedNCT04375241

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

Status
Completed
Phase
Study type
Observational
Enrollment
2,168 (actual)
Sponsor
Diagram B.V. · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all. The main objectives are: * To examine the feasibility of screening subjects of ≥65 years old for AAF. * To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

Detailed description

Study design: Prospective validation study.

Conditions

Interventions

TypeNameDescription
OTHERSubjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG DeviceSubjects with asymptomatic atrial fibrillation will be screened by using a Mobile ECG Device

Timeline

Start date
2018-07-02
Primary completion
2021-04-30
Completion
2021-04-30
First posted
2020-05-05
Last updated
2022-07-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04375241. Inclusion in this directory is not an endorsement.